Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Other Non Operating Income (2016 - 2025)

Medifast (MED) has disclosed Other Non Operating Income for 16 consecutive years, with $1000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income rose 100.26% year-over-year to $1000.0, compared with a TTM value of $3.1 million through Dec 2025, up 178.49%, and an annual FY2025 reading of $3.1 million, up 178.51% over the prior year.
  • Other Non Operating Income was $1000.0 for Q4 2025 at Medifast, up from -$2000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $2.6 million in Q2 2025 and bottomed at -$4.1 million in Q2 2024.
  • Average Other Non Operating Income over 5 years is -$43050.0, with a median of -$3000.0 recorded in 2022.
  • Peak annual rise in Other Non Operating Income hit 242300.0% in 2024, while the deepest fall reached 26685.71% in 2024.
  • Year by year, Other Non Operating Income stood at $7000.0 in 2021, then crashed by 228.57% to -$9000.0 in 2022, then tumbled by 455.56% to -$50000.0 in 2023, then crashed by 674.0% to -$387000.0 in 2024, then surged by 100.26% to $1000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for MED at $1000.0 in Q4 2025, -$2000.0 in Q3 2025, and $2.6 million in Q2 2025.